Clinical trials · Michigan
Congenital Diaphragmatic Hernia clinical trials in Michigan
We’re tracking 3 recruiting congenital diaphragmatic hernia studies with a site in Michigan — including Phase 4 studies, each written for real people, not researchers.
Recruiting studies in Michigan
- NCT05213676RecruitingPhase 4
Testing stopping inhaled nitric oxide in newborns with CDH
This trial studies whether stopping inhaled nitric oxide (a breathing medicine) can be safely used in newborns with congenital diaphragmatic hernia (CDH). It may help the team decide the best way to use this medicine during early newborn care.
Ann Arbor, MichiganAges birth–1 month - NCT00950118Recruiting
Study for people with congenital diaphragmatic hernia or family history
This study is for people who have a congenital diaphragmatic hernia (a birth-related opening in the diaphragm) or whose family member has had one. The research aims to learn more about the condition using molecular (cell-level) science, which may help improve understanding and future care.
Ann Arbor, MichiganAges Any age - NCT07577414Recruiting
Fetal Treatment for Congenital Diaphragmatic Hernia
This trial tests a procedure called FETO (fetoscopic endoluminal tracheal occlusion) performed during pregnancy to help babies with congenital diaphragmatic hernia—a birth defect where part of the diaphragm (breathing muscle) has a hole and organs from the belly move into the chest. The procedure temporarily blocks the baby's windpipe to help the lungs grow bigger before birth.
Ann Arbor, MichiganAges 18 years+
Congenital Diaphragmatic Hernia trials by city in Michigan
Where these studies are running in Michigan
Institutions with a site for the recruiting congenital diaphragmatic hernia studies listed above.
- University of Michigan · 3 studies
What taking part in a congenital diaphragmatic hernia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Congenital Diaphragmatic Hernia trials in other states
Common questions
- Are there congenital diaphragmatic hernia clinical trials in Michigan?
- Yes. We're currently tracking 3 recruiting congenital diaphragmatic hernia studies with a site in Michigan, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a congenital diaphragmatic hernia study in Michigan?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Michigan to take part?
- Not necessarily. These studies have a site in Michigan, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a congenital diaphragmatic hernia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New congenital diaphragmatic hernia studies open in Michigan regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.